DocGo (NASDAQ:DCGO – Get Free Report) and Gaxos.ai (NASDAQ:GXAI – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.
Profitability
This table compares DocGo and Gaxos.ai’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -65.29% | -40.42% | -24.81% |
| Gaxos.ai | -64.81% | -38.79% | -36.99% |
Valuation and Earnings
This table compares DocGo and Gaxos.ai”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.11 | -$182.40 million | ($1.96) | -0.18 |
| Gaxos.ai | $6.01 million | 1.07 | -$3.90 million | ($0.50) | -1.20 |
Gaxos.ai has lower revenue, but higher earnings than DocGo. Gaxos.ai is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings for DocGo and Gaxos.ai, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 2 | 3 | 0 | 2.33 |
| Gaxos.ai | 1 | 0 | 0 | 0 | 1.00 |
DocGo presently has a consensus price target of $2.38, indicating a potential upside of 561.19%. Given DocGo’s stronger consensus rating and higher possible upside, research analysts plainly believe DocGo is more favorable than Gaxos.ai.
Volatility and Risk
DocGo has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Gaxos.ai has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
Institutional & Insider Ownership
56.4% of DocGo shares are held by institutional investors. Comparatively, 42.6% of Gaxos.ai shares are held by institutional investors. 5.1% of DocGo shares are held by insiders. Comparatively, 3.2% of Gaxos.ai shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
DocGo beats Gaxos.ai on 8 of the 14 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About Gaxos.ai
Gaxos.ai Inc. engages in developing artificial intelligence applications for various sectors. Its portfolio includes applications in mental and physical wellbeing, coaching, and gaming. In addition, it offers Gaxos, a gaming platform develop, design, acquire, and manage conventional games and combine these games with unconventional game mechanisms. The company was formerly known as The NFT Gaming Company, Inc. and changed its name to Gaxos.ai Inc. in January 2024. Gaxos.ai Inc. was incorporated in 2021 and is based in Roseland, New Jersey.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
